NDC 71858-0010-02 - Tirosint
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 71858-0010
- Requested NDC
- 71858-0010-02
- Package NDCs from labels
- 71858-0010-4, 71858-0010-1, 71858-0010-2, 71858-0010-02
- Manufacturer
- IBSA Pharma Inc.
- Effective date
- 2026-03-25
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Tirosint - IBSA Pharma Inc. | IBSA Pharma Inc. | 2026-03-25 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 71858-0010-1 | Tirosint | 1 in 1 CARTON | CAPSULE | 1 | 13 | |
| 71858-0010-1 | Tirosint | 10 in 1 BLISTER PACK | CAPSULE | 10 | 13 | |
| 71858-0010-2 | Tirosint | 3 in 1 CARTON | CAPSULE | 3 | 13 | |
| 71858-0010-2 | Tirosint | 10 in 1 BLISTER PACK | CAPSULE | 10 | 13 | |
| 71858-0010-4 | Tirosint | 10 in 1 BLISTER PACK | CAPSULE | 10 | 13 | |
| 71858-0010-4 | Tirosint | 3 in 1 CARTON | CAPSULE | 3 | 13 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 71858-0010 | TIROSINT (LEVOTHYROXINE SODIUM) CAPSULE [IBSA PHARMA INC.] | 11 | Current NDC, Legacy NDC, 6 package rows | 20241027_7a7ade79-0165-4e31-b84e-667416c00c7e.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 71858-0010-4 | EA - Each | 71858-0010 | 8f761cf5-7112-4857-b7b7-8b5c293cc319 | 1 | 2018-12-13 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Meijer Dry Eye Relief | GLYCERIN, HYPROMELLOSE, POLYETHYLENE GLYCOL 400 | Meijer Distribution, Inc. | 9feaa5e2-6aca-96e8-e053-2a95a90a54bd | 2023-12-22 | Warnings | PDC6A3C0OX |
| Walgreens Multi-Symptom Relief Eye Drops | GLYCERIN, HYPROMELLOSE, POLYETHYLENE GLYCOL 400, TETRAHYDROZOLINE HCL, ZINC SULFATE | Walgreen Co. | a03789ce-66bd-7b12-e053-2995a90af85a | 2023-12-20 | Warnings | PDC6A3C0OX |
| Walgreens Eye Drops Maximum Redness Relief 15mL | GLYCERIN, NAPHAZOLINE HCI | Walgreen Company | 949d4a4d-b0f8-81f8-e053-2995a90a818d | 2023-12-20 | Warnings | PDC6A3C0OX |
| Walgreens Redness Relief Eye Drops 15mL | GLYCERIN, NAPHAZOLINE HCI | Walgreen Company | 94a0d08a-a6db-1088-e053-2995a90ab4fd | 2023-12-20 | Warnings | PDC6A3C0OX |
| Target Eye Drops Maximum Redness Relief Eye | GLYCERIN, NAPHAZOLINE HYDROCHLORIDE | Target Corporation | 1b26cd3b-4a05-4623-b320-01f22b3106ff | 2023-12-20 | Warnings | PDC6A3C0OX |
| TopCare Health Dry Eye Relief Eye Drops | GLYCERIN, HYPROMELLOSE, POLYETHYLENE GLYCOL 400 | Topco Associates LLC | 9c617e34-fc66-1a5b-e053-2995a90ace2c | 2023-12-20 | Warnings | PDC6A3C0OX |
| HEB Dry Eye Eye Drops | GLYCERIN, HYPROMELLOSE, POLYETHYLENE GLYCOL 400 | HEB | f80023cf-8e42-780a-e053-6294a90a66cd | 2023-12-20 | Warnings | PDC6A3C0OX |
| Topcare Maximum Redness Relief Eye Drops | GLYCERIN, NAPHAZOLINE HYDROCHLORIDE | Topco Assoc LLC | 9c6193a6-d824-1b27-e053-2995a90ab3cf | 2023-12-20 | Warnings | PDC6A3C0OX |
| Cleareyes Redness Relief | NAPHAZOLINE HYDROCHLORIDE AND GLYCERIN | Lil' Drug Store Products, Inc. | 39e4ab2b-ae12-4339-b219-109cf0f7f06a | 2023-12-15 | Warnings | PDC6A3C0OX |
| GenTeal Tears (Moderate) | DEXTRAN 70, GLYCERIN, HYPROMELLOSE | Alcon Laboratories, Inc. | a2992597-3490-6a5c-be45-2b6fa15e1547 | 2023-12-15 | Warnings | PDC6A3C0OX |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 804d64c9-9804-4d6d-adb2-5036c0be8b5c | 2023-12-12 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| La Roche Posay Laboratoire Dermatologique Cicaplast Defense B5 Skin Protectant | GLYCERIN | L'Oreal USA Products Inc | 32eaaaab-41bd-4efe-a71d-92e3a702c1e5 | 2023-12-11 | Warnings | PDC6A3C0OX |
| La Roche Posay Laboratoire Dermatologique Cicaplast Defense B5 | GLYCERIN | Cosmetique Active Production | 01c8a0d5-bcd1-4639-be45-530a226401f0 | 2023-12-11 | Warnings | PDC6A3C0OX |
| Hemorrhoidal Pain Relief Cream | GLYCERIN, PHENYLEPHRINE HCL, PRAMOXINE HCL, WHITE PETROLATUM | WALGREENS | 03bbe146-f185-bcfa-e063-6394a90a85bf | 2023-12-04 | Warnings | PDC6A3C0OX |
| Eye Wash | WATER | Jiangxi Zhenmei Biological Technology Co.,Ltd | c68795b8-bf68-0d01-e053-2a95a90abebb | 2023-12-04 | Warnings | 059QF0KO0R |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Proficient Rx LP | 89df6a0f-6602-4c22-a052-b565ea8368a7 | 2023-12-01 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Bloop Hemorrhoid Relief Topical | GLYCERIN, PETROLATUM, PHENYLEPHRINE HCL, PRAMOXINE HCL | Three Nations Corp | 0b6419e3-f1c7-bdfe-e063-6294a90a5d92 | 2023-11-30 | Warnings | PDC6A3C0OX |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 60a0bc29-4283-4ae9-9173-5caf9266f723 | 2023-11-16 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 970b8456-5b9a-4839-9222-4ec1302266e2 | 2023-11-02 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Family Wellness | GLYCERIN, PHENYLEPHRINE HCL, PRAMOXINE HCL, PETROLATUM | FRONT PHARMACEUTICAL PLC | eb1785f4-5876-443b-b175-9b59d65d1a48 | 2023-10-26 | Warnings | PDC6A3C0OX |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.